The Protective Effects of Probiotic-Fermented Soymilk on High-Fat Diet-Induced Hyperlipidemia and Liver Injury

Xiao-lei Zhang,Yan-feng Wu,Yu-shan Wang,Xin-zhe Wang,Chun-hong Piao,Jun-mei Liu,Yan-long Liu,Yu-hua Wang

DOI: https://doi.org/10.1016/j.jff.2017.01.002

IF: 5.6

2017-01-01

Journal of Functional Foods

Abstract:The effects of probiotic-fermented soymilk (fermented by mixture of Bifidobacterium bifidum, Lactobacillus casei, and L. plantarum) on high-fat diet (HFD)-induced hyperlipidemia and liver injury were examined. C57BL/6N mice were randomly assigned into four groups that were treated with different diets: normal chow (NC), HFD, HFD with probiotic-fermented soymilk and HFD with non-fermented soymilk. After treatment for 6 weeks, probiotic-fermented soymilk treatment significantly reduced HFD-induced body weight gain, hyperlipidemia, liver fat accumulation and reactive oxygen species (ROS) production. In addition, probiotic-fermented soymilk consumption significantly reduced the levels of serum alanine aminotransferase (ALT), lipopolysaccharide (LPS), and liver tumor necrosis factor-α (TNF-α) compared with the HFD treatment. Further, probiotic-fermented soymilk significantly increased the serum leptin level. In conclusion, probiotic-fermented soymilk reduced hyperlipidemia and liver injury induced by HFD. The role of probiotic-fermented soymilk may decrease the production of liver LPS, TNF-α, and oxidative stress and induce adipose leptin and triacylglycerol hydrolase (TGH) production.